Zhou Hui, Luo Yilin, Li Shiguang, Zhang Guoping, Zeng Xianchun
Department of Radiology, The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China.
Department of Nuclear Medicine, Guizhou Provincial People's Hospital, Guiyang, China.
Medicine (Baltimore). 2025 Jun 20;104(25):e42862. doi: 10.1097/MD.0000000000042862.
This study aims to explore research hotspots and development trends in molecular imaging of glioma from 2014 to 2024.
A total of 2957 publications indexed in the web of science core collection (WoSCC) were analyzed using bibliometric techniques. To visualize the research landscape, co-citation clustering, keyword analysis, and technological trend mapping were performed using CiteSpace and Excel.
Publication output peaked in 2021. Emerging research trends included the integration of radiomics and artificial intelligence and the application of novel imaging modalities such as positron emission tomography and magnetic resonance spectroscopy. Significant progress was observed in blood-brain barrier disruption techniques and the development of molecular probes, especially those targeting IDH and MGMT mutations.
Molecular imaging has been pivotal in advancing glioma research, contributing to improved diagnostic accuracy and personalized treatment strategies. However, challenges such as clinical translation and standardization remain. Future studies should focus on integrating advanced technologies into routine clinical practice to enhance patient care.
本研究旨在探讨2014年至2024年胶质瘤分子成像的研究热点和发展趋势。
使用文献计量学技术对科学引文索引核心合集(WoSCC)中索引的2957篇出版物进行分析。为了可视化研究格局,使用CiteSpace和Excel进行共被引聚类、关键词分析和技术趋势映射。
出版物产出在2021年达到峰值。新兴研究趋势包括放射组学与人工智能的整合以及正电子发射断层扫描和磁共振波谱等新型成像模态的应用。在血脑屏障破坏技术和分子探针的开发方面取得了显著进展,尤其是针对异柠檬酸脱氢酶(IDH)和O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)突变的探针。
分子成像在推进胶质瘤研究方面发挥了关键作用,有助于提高诊断准确性和个性化治疗策略。然而,临床转化和标准化等挑战仍然存在。未来的研究应专注于将先进技术整合到常规临床实践中,以改善患者护理。